Clinical Ink announced that it entered into a collaboration with Tandem Diabetes Care to integrate (AID) data.

While a US Fed rate cut and falling energy prices provided some support, aggressive buying is needed immediately to salvage ...

Tandem Diabetes Care's top-line growth hasn't been great over the past few years. If it can successfully address challenges detrimental to revenue growth, it may become an attractive stock -- even ...

Rosen Law Firm’s probe into Tandem Diabetes Care (TNDM) after a voluntary correction of certain t:slim X2 insulin pumps, and the roughly 20% share drop that followed, has investors reassessing risk ...

Igor Shesterkin has played up to lofty preseason expectations. Bruce Bennett / Getty Images We’ve passed the quarter mark of the regular season, so it’s a good time to check in on how all 32 goalie ...